FDA Inspection
Metropolitan Reproductive Medicine, P.C.Metropolitan Reproductive Medicine, P.C. – FDA Inspection, Dec 14, 2012
Record Details
This FDA Inspection record concerns Metropolitan Reproductive Medicine, P.C., with an inspection on December 14, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 14, 2012
- Product Type
- Biologics
View Company Profile
ID · 7cd48794-6eb7-4a35-a79d-e682712dfbff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 810165
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Metropolitan Reproductive Medicine, P.C.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 13, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 25, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 27, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 25, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Metropolitan Reproductive Medicine, P.C.
- FDA Inspection 1181504 - 2022-10-13
- FDA Inspection 1094874 - 2019-06-25
- FDA Inspection 1000715 - 2017-01-27
- FDA Inspection 904067 - 2014-11-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.